Clough Capital Partners’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-751,101
| Closed | -$5.33M | – | 160 |
|
|
2017
Q3 | $5.33M | Buy |
751,101
+488,800
| +186% | +$3.47M | 0.36% | 68 |
|
|
2017
Q2 | $1.9M | Buy |
262,301
+155,601
| +146% | +$1.12M | 0.13% | 88 |
|
|
2017
Q1 | $657K | Buy |
106,700
+28,100
| +36% | +$173K | 0.04% | 115 |
|
|
2016
Q4 | $461K | Buy |
78,600
+45,000
| +134% | +$264K | 0.03% | 147 |
|
|
2016
Q3 | $178K | Sell |
33,600
-846,300
| -96% | -$4.48M | 0.01% | 170 |
|
|
2016
Q2 | $5.83M | Buy |
879,900
+9,700
| +1% | +$64.2K | 0.31% | 99 |
|
|
2016
Q1 | $4.06M | Sell |
870,200
-832,900
| -49% | -$3.89M | 0.19% | 116 |
|
|
2015
Q4 | $8.6M | Buy |
1,703,100
+70,800
| +4% | +$358K | 0.4% | 79 |
|
|
2015
Q3 | $5.75M | Buy |
+1,632,300
| New | +$5.75M | 0.25% | 89 |
|